Pharma stocks plunge as Trump’s 100% tariffs send shockwaves across Asia.
Hosted by Michelle Martin, we break down the impact on Singapore’s $4 billion pharma exports, Sumitomo Pharma, CSL, and more. Are these tariffs a short-term blow or a long-term reset for Asian healthcare investments?
Plus, we spotlight Mapletree’s three Singapore REITs - Logistics, Industrial, and Pan-Asia Commercial - amid expected rate cuts.
Which one offers the best dividend yield and growth potential?
Dividend Titan’s Willie Keng shares his strategy for navigating healthcare risks and REIT opportunities.

Money and Me: Finding the Winners That Matter in 2026
18:00

Market View: Is the AI trade back on?
21:49

Money and Me: The S-REIT Comeback - Income, Upgrades and What to Buy in 2026
20:16